Keywords
Side Effects
Antiepileptic Drugs
Duration of Treatment
How to Cite
Abstract
Epilepsy is one of the most common neurological diseases that can affect people of all ages, races, social classes, and geographic locations. Epilepsy is caused by abnormal release of neurons in the brain characterized by seizures. Data from the World Health Organization shows that epilepsy accounts for a significant proportion of the world's disease burden, affecting nearly 50 million people worldwide. The goal of management of epilepsy patients is to control seizures and improve quality of life. However, the side effects of antiepileptic drugs can significantly impair quality of life. This study aims to determine the relationship between duration of treatment and types of antiepileptic drugs with side effects of drugs in epilepsy patients at RSUDZA Neurology outpatient clinic. This is an observational analytic study with a cross sectional design. The sample of this study was epileptic patients at RSUDZA Neurology Outpatient Clinic based on inclusion and exclusion criteria with a total of 42 samples. Sampling was carried out from May−September 2022 using a consecutive sampling technique and filling out the Liverpool Adverse Effect Profile (LAEP) questionnaire. Existing research sample data were tabulated and analyzed by univariate analysis to present the frequency and percentage. Spearman's correlation statistical test was used to test the relationship between variables. The patients consisting of 17 men (40.5%) and 25 women (59.5%). The average length of treatment that respondents had undergone was 52 months, all of whom experienced side effects of antiepileptic drugs. The results of the Spearman's correlation statistical test showed that there was no relationship between the length of treatment and the type of antiepileptic drug with drug side effects in patients diagnosed with epilepsy at RSUDZA Neurology Outpatient Clinic.
References
Abou-Khalil, B. W. (2019). Update on Antiepileptic Drugs. Continuum Lifelong Learning in Neurology, 25, 508–536. https://doi.org/10.1212/CON.0000000000000715.
Balestrini, S., Arzimanoglou, A., Blumcke, I., Scheffer, I. E., Wiebe, S., & Zelano, J. (2021). The aetiologies of epilepsy. Epileptic Disord, 23, 1–16. https://doi.org/10.1684/EPD.2021.1255.
Beghi, E. (2020). The Epidemiology of Epilepsy. Neuroepidemiology ,54, 185–191. https://doi.org/10.1159/000503831.
Budikayanti, A., Qadri, L. M., Syeban, Z., Indrawati, L. A., & Octaviana, F. (2018). Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile. Neurol Res Int, 181, 1−6. https://doi.org/10.1155/2018/8490639.
Chen, B., Choi, H., Hirsch, L. J., Katz, H., Legge, A., & Buchsbaum, R. (2017). Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav, 76, 24–31. https://doi.org/10.1016/j.yebeh.2017.08.039.
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, J. E., & Curtis (2018). Epilepsy. Nat Rev Dis Prim, 4, 18025. https://doi.org/10.1038/nrdp.2018.24.
Falco-Walter, J. (2020). Epilepsy-Definition, Classification, Pathophysiology, and Epidemiology. Seminars in Neurology, 40(6), 617–623. https://doi.org/10.1055/s-0040-1718719.
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., & Elger, J. E. (2014). ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia, 55(4), 475–482. https://doi.org/10.1111/epi.12550.
Fisher, R. S., Cross, J.H., D'Souza, C., French, J. A., Haut, S. R., & Higurashi, N. (2017). Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia, 58(4), 531–542, https://doi.org/10.1111/epi.13671.
Huff, J. S., & Murr, N. (2021). Seizure. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK430765/. Diunduh 16 Mei 2022.
Kwon, O.Y., & Park, S. P. (2018). Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy. J Epilepsy Res, 8(2), 74–80. https://doi.org/10.14581/jer.18012.
Maryam, I. S., Wijayanti, I. A. S., & Tini, K. (2018). Karakteristik Pasien Epilepsi Di Poliklinik Saraf Rumah Sakit Umum Pusat Sanglah Periode Januari−Desember 2016. Callosum Neurology 1 (3), 91–96. https://doi.org/10.29342/cnj.v1i3.29.
Pack, A. M. (2019). Epilepsy Overview and Revised Classification of Seizures and Epilepsies. Continuum Lifelong Learning in Neurology, 25(2), 306–321. https://doi.org/10.1212/con.0000000000000707.
Panelli, R. J., Killpatrick, C., Moore, S. M., Matkovic, Z., D'Souza, W. J., & O'Brien, T. J. (2007). The Liverpool adverse events profile: Relation to AED use and mood. Epilepsia, 48(3), 456–463. https://doi.org/10.1111/j.1528-1167.2006.00956.x.
Perucca, E. (2021). The pharmacological treatment of epilepsy: recent advances and future perspectives. Acta Epileptologica, 3(1), 1−11. https://doi.org/10.1186/s42494-021-00055-z.
Thijs, R. D., Durges, R., O'Brien, T. J., & Sander, J. W. (2019). Epilepsy in adults. The Lancet 393(10172), 689–701. https://doi.org/10.1016/S0140-6736(18)32596-0.
Tedyanto, E. H., Chandra, L., & Adam, O. M. (2020). Gambaran Penggunaan Obat Anti Epilepsi (OAE) pada Penderita Epilepsi Berdasarkan Tipe Kejang di Poli Saraf Rumkital DR. Ramelan Surabaya. J Ilm Kedokt Wijaya Kusuma 9(1), 77. http://dx.doi.org/10.30742/jikw.v9i1.748.
Tomson, T., Battino, D., & Perucca, E. (2019). Teratogenicity of antiepileptic drugs. Curr Opin Neurol, 32(2), 246–252. https://doi.org/10.1097/WCO.0000000000000659.
WHO. (2022). Epilepsy. Available at: https://www.who.int/news-room/fact-sheets/detail/epilepsy. Diunduh 10 May 2022.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Nova Dian Lestari Lestari, Sri Hastuti, Nur Astini